Why Oncotarget Should Be Your Primary Source of Scientific Journals

Several reasons exist as to why someone may want to proceed with making Oncotarget one of their first choice of sources for researching. It’s known to be a multidisciplinary journal which provides users with access for free. It lists and publishes weekly papers by Impact Journals, or issues from sources that are found and made available online. Every issue can be printed for special demands. The goal ultimately is to have effects of producing scientific results with speediness while making them available on a wide basis.

The website has been engineered and designed primarily for the purposes of working towards advancements in science with goals of ultimately achieving advancements in society. In order to achieve advancements in society, it’s going to be necessary to ensure that advancements in science are being made or worked towards. Someone may utilize the website to become a better writer also. It’s a medical journal that focuses on the field of oncology. The final and ultimate goal is referred to users wanting a society in which no diseases will exist. If we’re able to achieve that as humanity, then Oncotarget will have no problem ceasing its functionality as a website as their goal would essentially be achieved. Any advancements made in science is an advancement for Oncotarget even if it didn’t directly have any impacts on the advacements/improvements that have been made. Oncotarget is a website that is truly about the progress of humanity as opposed to being about self-recognition (in this case, as a website.)

Oncotarget is also understanding of the fact that in order for the world to be considered a better place for us to live in, we are going to be required as a human race to work together that that the necessary changes that are required for us to work towards perfection can be made. There’s no doubts about the fact that science has certainly advanced from quite a while ago and we should continue to recognize that so that we can remind ourselves what the possibilities are if we simply keep on working and making steps towards advancements each and every day. Follow Oncotarget journal on Twitter

Everything You Should Know About Eric Lefkofsky

Mr. Lefkofsky is an entrepreneur, who is the CEO and founder of Tempus. Additionally, he has co-founded other organizations such as Groupon, ECHO, INWK, Uptake, and Mediaocean. He is the co-founder of Lightbank, a Chicago-based venture capital firm. Lightbank has investments in over 100 companies. One of these investments is in the dating app, Coffee Meets Bagel. Another company is BeachMint, an e-commerce company. He was brought up in Southfield, Michigan and studied for his undergraduate and law degrees at the University of Michigan.

 

His Entrepreneurial Spirit

 

Lefkofsky has always been an entrepreneur. His first business was selling carpets while at the University of Michigan. When he completed school, he teamed up with his friend and they borrowed money, which they used to start an apparel company in Madison, Wisconsin. They, later on, created an internet-based company, which specialised in promotional products. They eventually sold their small internet startup in 2000.

 

Eric Lefkofsky and Cancer Research

 

Together with his wife Liz, they have donated a lot of money to cancer research. Most of their donations have been through the Lefkofsky family foundation. For instance, in 2015, he donated a million dollars to the Robert H. Lurie Comprehensive Cancer Center. A month before that, the foundation had donated half a million dollars to gastric cancer research conducted at Stanford University. In November of 2016, the foundation gave a quarter a million to the Weill Cornell Medicine, which is involved in breast cancer research.

Eric Lefkofsky has donated millions of dollars to cancer research in his life. However, with his new effort, he will be able to fight cancer in a better way. His new organization, known as Tempus allows him to take a smarter approach in the fight against cancer.

Since leaving his position as CEO of Groupon, most of his time has been spent creating Tempus. The startup has mostly been operating out of Lightbank, another of Lefkofsky’s startups. The level at which he works in Tempus is not quite clear. However, it is quite clear that he plays a major role there.

Visit: https://www.facebook.com/eplefkofsky/

What is Tempus?

 

On its website, the organization says its work is to facilitate professionals involved in cancer treatment more efficient. It does this by assisting them to make data-driven decisions in real time. According to the website, the organization utilizes genome sequencing and analyses to assist doctors to understand their patients’ tumors.

The organization relies on the collection of huge amounts of genomic information. It then utilizes complex data analysis to help doctors give their patients personalized medical solutions. The aim is to ensure that patients get the best care plan possible. Currently, the company only specializes in research for lung, breast, and pancreatic cancer. However, it hopes to add more types of cancer as time progresses.

Tempus currently employs 29 people. One of its notable employees is Hunter, who was formally a director at HighGround. Another notable person at Tempus is the VP of Engineering at Tempus Anil Saldanha. The VP was formally alum at Trustwave. Additionally, a former VC at Lightbank, Ryan Fukushima now holds an executive role at the organization.

More about Lefkofsky’s ventures can be read here.